Hyperfine, INC 10-Q quarterly reports

Hyperfine, Inc. reports a Q3 2025 net loss of $11.0 million on declining sales, while securing $18.4 million in net proceeds from an October 2025 public offering.

Hyperfine, Inc. reported a 30.2% decrease in total sales for the first six months of 2025, alongside new FDA clearances for its AI-powered Swoop system and a $5.2 million capital raise.

Hyperfine's Q1 2025 revenue decreased due to lower device sales, despite cost-cutting measures and international expansion efforts.

Hyperfine Inc. saw a significant increase in revenue and unit sales of its Swoop Portable MR Imaging System in the third quarter of 2024, while continuing to manage operating expenses.

Hyperfine Inc. saw a revenue increase in the second quarter of 2024, driven by device and service sales, while still experiencing a net loss.

Hyperfine Inc. saw a 25% increase in revenue in the first quarter of 2024 compared to the same period last year, driven by higher device sales and service revenue, while also reducing operating expenses.